 | 28 Healthcare Stocks Moving In Thursday's Pre-Market Session
www.msn.com - September 13 at 9:47 AM |
 | Adverum Biotechnologies (NASDAQ:ADVM) Given New $8.00 Price Target at SunTrust Banks
www.americanbankingnews.com - September 13 at 9:05 AM |
| Chardan Capital Cuts Adverum Biotechnologies (NASDAQ:ADVM) Price Target to $6.00
www.americanbankingnews.com - September 13 at 8:19 AM |
 | Does This Macular Degeneration Study Deserve More Credit?
247wallst.com - September 12 at 4:43 PM |
 | Adverum Bio down 3% premarket on data from early-stage ADVM-022 IVT gene therapy trial
seekingalpha.com - September 12 at 4:43 PM |
 | Here's Why Adverum's Shares Saw a Lower Price Today
www.fool.com - September 12 at 4:43 PM |
 | Adverum Biotechnologies Reports Positive 24-Week Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy to Treat Wet AMD
finance.yahoo.com - September 12 at 4:43 PM |
| Adverum Shares Sink After Phase 1 Readout From Wet AMD Gene Therapy Trial
finance.yahoo.com - September 12 at 4:43 PM |
| Adverum Biotechnologies Inc (NASDAQ:ADVM) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - September 11 at 2:12 AM |
| Adverum Biotechnologies Inc (NASDAQ:ADVM) Expected to Post Quarterly Sales of $480,000.00
www.americanbankingnews.com - September 11 at 1:50 AM |
| Zacks: Brokerages Anticipate Adverum Biotechnologies Inc (NASDAQ:ADVM) Will Post Earnings of -$0.27 Per Share
www.americanbankingnews.com - September 9 at 7:15 PM |
| Adverum Biotechnologies to Host a Conference Call and Webcast to Present 24-week Data from First Cohort of OPTIC Trial of ADVM-022 Intravitreal Injection Gene Therapy to Treat Wet AMD at Retina Society 2019 Annual Meeting
finance.yahoo.com - September 5 at 11:18 AM |
| Stock Traders Purchase High Volume of Adverum Biotechnologies Call Options (NASDAQ:ADVM)
www.americanbankingnews.com - September 5 at 7:45 AM |
| The Keys to Successfully Timing the Markets - September 04, 2019
finance.yahoo.com - September 4 at 9:45 AM |
| Adverum Biotechnologies to Present 24-Week Data from First Cohort of OPTIC Trial of ADVM-022 Intravitreal Injection Gene Therapy to Treat Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting in October
finance.yahoo.com - August 29 at 7:43 AM |
| Is the Options Market Predicting a Spike in Adverum Biotechnologies (ADVM) Stock?
finance.yahoo.com - August 27 at 8:16 PM |
| The Keys to Successful Timing the Markets - August 15, 2019
finance.yahoo.com - August 15 at 11:09 AM |
| Edited Transcript of ADVM earnings conference call or presentation 8-Aug-19 8:30pm GMT
finance.yahoo.com - August 12 at 11:46 AM |
| Adverum Biotechnologies EPS beats by $0.04
seekingalpha.com - August 9 at 8:27 AM |
| Adverum Biotechnologies (ADVM) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 9 at 8:27 AM |
 | Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Should You Buy?
www.nasdaq.com - August 2 at 12:58 AM |
| Is the Options Market Predicting a Spike in Adverum (ADVM) Stock?
finance.yahoo.com - July 27 at 8:44 AM |
| Adverum Biotechnologies to Host a Conference Call and Webcast to Report Second Quarter 2019 Financial Results and Provide Corporate Updates
finance.yahoo.com - July 26 at 7:26 AM |
| What Makes Adverum Biotechnologies (ADVM) a New Strong Buy Stock
finance.yahoo.com - July 16 at 7:23 PM |
| 5 Best Biotech Stocks of 2019 So Far
finance.yahoo.com - July 12 at 8:19 AM |
| Adverum (ADVM) Jumps: Stock Rises 5.1%
finance.yahoo.com - July 11 at 6:30 PM |
 | ADVM's Rise From $4 To $14; Did You Ride The Rally?
www.rttnews.com - July 9 at 6:35 AM |
| Adverum up 10% ahead of ADVM-022 data readout
seekingalpha.com - July 8 at 6:54 PM |
| Adverum Biotechnologies to Present Data at Upcoming Conferences
finance.yahoo.com - July 8 at 8:13 AM |
| 3 Biotechs That Have Doubled This Year (Acquisition Next?)
finance.yahoo.com - July 2 at 6:44 PM |
| The Adverum Biotechnologies (NASDAQ:ADVM) Share Price Has Gained 252%, So Why Not Pay It Some Attention?
finance.yahoo.com - June 23 at 6:37 PM |
| Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022 Gene Therapy for Wet AMD
finance.yahoo.com - June 10 at 6:56 PM |
| Adverum Biotechnologies: A High Risk/High Reward Biotech Play In 2019
seekingalpha.com - May 25 at 8:13 AM |
| Adverum Biotechnologies, Inc. (ADVM) Shares March Higher, Can It Continue?
finance.yahoo.com - May 24 at 7:00 PM |
| Updated Investment Thesis On Adverum Biotechnologies
seekingalpha.com - May 21 at 6:15 AM |
| All You Need to Know About Adverum Biotechnologies (ADVM) Rating Upgrade to Buy
www.nasdaq.com - May 18 at 6:48 AM |
 | Adverum Biotechnologies Inc.
www.barrons.com - May 16 at 7:49 PM |
| Adverum Biotechnologies Provides Update on OPTIC Phase 1 Trial for ADVM-022 in Wet AMD
finance.yahoo.com - May 16 at 7:49 PM |
 | Adverum Biotechnologies Reports First Quarter 2019 Financial Results and Provides Corporate Update
www.globenewswire.com - May 8 at 7:41 PM |
| Adverum Biotechnologies (ADVM) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 8 at 7:41 PM |
| Adverum Biotechnologies Announces Board Changes
finance.yahoo.com - May 2 at 8:04 PM |
| Adverum Biotechnologies to Present 30-month Preclinical Safety and Expression Data for ADVM-022 Gene Therapy in Wet AMD at the ASGCT 22nd Annual Meeting
finance.yahoo.com - May 2 at 8:19 AM |
| Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
finance.yahoo.com - May 1 at 7:32 PM |
| Adverum Biotechnologies Presents First Preclinical Data on Dosing Contralateral Eye with ADVM-022 Gene Therapy for Wet AMD at the ARVO 2019 Annual Meeting
finance.yahoo.com - April 30 at 6:57 PM |
| Adverum Biotechnologies Appoints Thomas Leung as Chief Financial Officer
finance.yahoo.com - April 24 at 6:41 PM |
| Adverum Announces Clinical Hold, But It Should Not Hinder Its Gene Therapy Path
seekingalpha.com - April 17 at 7:32 PM |
| Adverum Biotechnologies to Present New Preclinical Data on ADVM-022 Gene Therapy for Wet AMD at ASGCT and ARVO
finance.yahoo.com - April 16 at 7:50 PM |
| Adverum down 7% on FDA suspension of gene therapy trial
seekingalpha.com - April 15 at 7:30 PM |
 | Adverum Biotechnologies Provides Clinical Program Update on ADVM-022 Gene Therapy for Wet AMD
www.marketwatch.com - April 15 at 7:30 PM |
| Adverum Biotechnologies Provides Clinical Program Update on ADVM-022 Gene Therapy for Wet AMD
finance.yahoo.com - April 15 at 7:30 PM |
